DLBS1033, a protein extract from lumbricus rubellus, possesses antithrombotic and thrombolytic activities

49Citations
Citations of this article
86Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The medicinal value of earthworm has been widely known since the history of Asian ancient medicine. This present study aims to determine the mechanism of action and effect of a standardized extract of Lumbricus rubellus named as DLBS1033. The fibrinogen degradation, antiplatelet aggregation, and ex vivo antithrombotic assay using human blood were performed to study antithrombotic activity. Fibrin plate and clot lysis assay were also done to examine thrombolytic properties. DLBS1033 was found to possess fibrinogenolytic activity on -, -, and -chain of fibrinogen. It also induced antiplatelet aggregation and prolonged blood clotting time, which further confirmed its antithrombotic properties. In addition, thrombolytic properties of DLBS1033 were shown with its fast and long-acting fibrinolytic activity, as well as its effective blood clot lysis activities. In conclusion, DLBS1033 conferred antithrombotic and thrombolytic action which could be used as a safe and promising oral thrombolytic drug. Copyright 2011 Jessica Trisina et al.

Cite

CITATION STYLE

APA

Tjandrawinata, R. R., Trisina, J., Sunardi, F., & Suhartono, M. T. (2011). DLBS1033, a protein extract from lumbricus rubellus, possesses antithrombotic and thrombolytic activities. Journal of Biomedicine and Biotechnology, 2011. https://doi.org/10.1155/2011/519652

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free